Twilio ( TWLO ) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.Thursday, Aug. 7, 2025, 5 p.m. ETChief Executive Officer - Khozema ShipchandlerContinue reading ...
Henry Schein ( HSIC ) Q2 EPS Drops 11%
Henry Schein ( NASDAQ:HSIC ) , a healthcare solutions company focused on distributing dental and medical products, released its quarterly results on August 5, 2025. The quarter's most notable development was a drop in profitability, as both GAAP diluted EPS ( $0.70 ) and non-GAAP diluted EPS ( ...
Why Is Henry Schein Stock Falling Tuesday? - Henry Schein ( NASDAQ:HSIC )
Q2 EPS of $1.10 missed estimates by $0.10; revenue rose 3.3% to $3.34 billion, topping expectations. The company sees over $100 million in annual savings from restructuring, affirms 2025 EPS and revenue guidance. Get special access to three exclusive "Top 10 Stocks" power lists today, updated ...
Henry Schein Stock Falls on Q2 Earnings Miss, Revenues Top
HSIC slides after Q2 EPS misses estimates by 6.8%. Revenues beat with 3.2% growth and strength across key segments.
Henry Schein ( HSIC ) Q2 Earnings Lag Estimates
Henry Schein (HSIC) delivered earnings and revenue surprises of -6.78% and +0.60%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
McKesson ( MCK ) Earnings Expected to Grow: Should You Buy?
McKesson (MCK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Henry Schein ( HSIC ) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
Henry Schein (HSIC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Henry Schein to Report Q2 Earnings: What's in Store for the Stock?
HSIC eyes modest Q2 gains, with dental, medical and specialty segments showing signs of steady momentum.
Nasdaq To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Friday - Henry Schein ( NASDAQ:HSIC ) , Imax ( NYSE:IMAX )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Deutsche Bank raised Nasdaq, Inc. NDAQ price target from $97 to $105.
This Norfolk Southern Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday - Darling Ingredients ( NYSE:DAR ) , Dow ( NYSE:DOW )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Baird analyst Ben Kallo downgraded Darling Ingredients Inc.
What Does the Market Think About Henry Schein? - Henry Schein ( NASDAQ:HSIC )
Henry Schein's HSIC short percent of float has fallen 9.66% since its last report. The company recently reported that it has 7.24 million shares sold short, which is 6.64% of all regular shares that are available for trading.
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
This Procter & Gamble Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday - Henry Schein ( NASDAQ:HSIC ) , Best Buy Co ( NYSE:BBY )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Piper Sandler analyst Peter Keith downgraded the rating for Best Buy Co., Inc.
Why Henry Schein ( HSIC ) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Should You Retain Henry Schein Stock in Your Portfolio Right Now?
Investors are optimistic about HSIC, owing to the strong Henry Schein One performance. However, macro headwinds and fierce competition pose challenges.
What Does the Market Think About Henry Schein? - Henry Schein ( NASDAQ:HSIC )
Henry Schein's HSIC short percent of float has risen 19.87% since its last report. The company recently reported that it has 7.89 million shares sold short, which is 7.24% of all regular shares that are available for trading.
Henry Schein ( HSIC ) Up 6.5% Since Last Earnings Report: Can It Continue?
Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
SOLV's Strong Q1 Signals Turnaround: Is the Stock Worth Betting Now?
Solventum beats Q1 estimates, raises guidance, and powers ahead with transformation despite looming tariff headwinds.
Should You Retain Henry Schein Stock in Your Portfolio Right Now?
Investors are optimistic about HSIC, owing to the strong performance of its Henry Schein One business.
The Smart Money Is Buying These 10 Stocks - Apollo Global Management ( NYSE:APO ) , AppLovin ( NASDAQ:APP )
Private equity titans like Apollo, Blackstone and KKR have to reveal what stocks they own every quarter. Copying their investments has beaten the markets 4-to-1 since 2001. Here are KKR's top ten public holdings.
Veracyte Stock Gains on Q1 Earnings and Revenue Beat, Gross Margin Up
VCYT registers robust growth from its market-leading Decipher Prostate and Afirma tests in the first quarter of 2025.
These Analysts Lower Their Forecasts On Henry Schein Following Q1 Results - Henry Schein ( NASDAQ:HSIC )
Henry Schein Inc. HSIC reported mixed results for its first-quarter on Monday. The company posted adjusted EPS of $1.15, up 4.5% year over year, beat the consensus of $1.11. Sales were $3.17 billion, missing the consensus of $3.23 billion.
Clear Aligners Market Size Projected to Surge $21.75 Billion Growth by 2031, With CAGR of 18.8% | The Insight Partners
US & Canada, May 05, 2025 ( GLOBE NEWSWIRE ) -- According to a new comprehensive report from The Insight Partners, the global clear aligners market is growing owing to the increasing prevalence of dental problems such as malocclusion and surging demand for dental aesthetic solutions.
Henry Schein's Reports Mixed Bag Q1 Earnings, CEO Confident In Business Fundamentals - Henry Schein ( NASDAQ:HSIC )
Q1 adjusted EPS rose 4.5% to $1.15, topping estimates; sales of $3.17 billion missed the $3.23 billion consensus. Global Specialty Products sales rose 4.3% in constant currency, driven by implants, biomaterials, and acquisitions. Feel unsure about the market's next move?
Henry Schein Q1 Earnings Top Estimates, Revenues Miss, Stock Falls
HSIC ends the first quarter of 2025 on a mixed note.
Henry Schein ( HSIC ) Q1 Earnings Beat Estimates
Henry Schein (HSIC) delivered earnings and revenue surprises of 3.60% and 1.84%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
US Stocks Likely To Open Lower After S&P 500's 9-Day Streak: 'Any De-Escalation In Trade Tensions Should Be Positive,' Says Expert - Bon Natural Life ( NASDAQ:BON ) , Cummins ( NYSE:CMI )
U.S. stock futures fell on Monday after a nine-day winning streak on the S&P 500 index. Futures of major benchmark indices were lower in premarket. The S&P 500 index notched a nine-day advance for the first time since November 2004 on Friday.
Tyson Foods, Ford And 3 Stocks To Watch Heading Into Monday - Ford Motor ( NYSE:F ) , Cummins ( NYSE:CMI )
With U.S. stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Tyson Foods Inc. TSN to report quarterly earnings at 82 cents per share on revenue of $13.14 billion before the opening bell, according to data ...
McKesson ( MCK ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
McKesson (MCK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Becton Dickinson ( BDX ) Q2 Earnings Top Estimates
Becton Dickinson (BDX) delivered earnings and revenue surprises of 2.13% and 1.74%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Can Sustained Product Demand Drive CAH Stock Before Q3 Earnings?
The continued solid uptake of Cardinal Health's products is expected to have driven fiscal third-quarter revenues despite an uncertain macroeconomic environment.
Labcorp ( LH ) Beats Q1 Earnings Estimates
Labcorp (LH) delivered earnings and revenue surprises of 2.95% and 2.04%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Can Sustained Product Demand Drive BDX Stock Before Q2 Earnings?
The continued solid uptake of BD's products is expected to have driven fiscal second-quarter revenues despite transitory market dynamics.
Henry Schein ( HSIC ) Reports Next Week: Wall Street Expects Earnings Growth
Henry Schein (HSIC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
HSIC Gears Up for Q1 Earnings: Here's What You Need to Know
Henry Schein is expected to report impressive Q1 2025 sales in each of its business segment and a positive pace of recovery from the cyber incident.
Merit Medical ( MMSI ) Surges 8.3%: Is This an Indication of Further Gains?
Merit Medical (MMSI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Why Is Henry Schein ( HSIC ) Down 3.9% Since Last Earnings Report?
Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Intravenous Equipment Market is Projected US$ 35,2670 Million, Expanding at 5.9% CAGR by 2035 | Fact.MR Analysis
Rockville, MD, March 20, 2025 ( GLOBE NEWSWIRE ) -- According to Fact.MR, a market research and competitive intelligence provider, the global intravenous ( IV ) equipment market is estimated to reach a valuation of US$ 19,881 million in 2025 and is expected to grow at a CAGR of 5.9% during the ...
U.K. Surgical Pledgets Market Size to Reach US$27.5 Mn by 2034, Driven by Rising Cardiovascular Disorders and Expanding Geriatric Population - Latest Report by Transparency Market Research Inc.
Wilmington, Delaware, Transparency Market Research Inc. -, Feb. 27, 2025 ( GLOBE NEWSWIRE ) -- The U.K. surgical pledgets market ( Markt für chirurgische Hilfsmittel ) , valued at approximately US$15.3 million in 2023, is projected to experience robust growth at a CAGR of 5.5% from 2024 to 2034, ...
CrowdStrike To Rally Over 18%? Here Are 10 Top Analyst Forecasts For Wednesday - Agilon Health ( NYSE:AGL ) , Maplebear ( NASDAQ:CART )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. UBS cut Henry Schein, Inc. HSIC price target from $83 to $80. UBS analyst Kevin Caliendo maintained a ...
Henry Schein Q4 Earnings And Outlook Miss Expectations, Restructures For Growth - Henry Schein ( NASDAQ:HSIC )
Henry Schein posted Q4 adjusted EPS of $1.19, missing the $1.21 consensus. Sales grew 5.8% to $3.19B, below the $3.30B estimate. 2025 guidance projects adjusted EPS of $4.80-$4.94, missing the $5.01 consensus. Sales growth is expected at 2%-4% over 2024.
HSIC Q4 Earnings Match Estimates, Margins Up, Stock Falls in Premarket
Henry Schein's fourth-quarter results reflect stable dental and medical end-markets.
Henry Schein ( HSIC ) Meets Q4 Earnings Estimates
Henry Schein (HSIC) delivered earnings and revenue surprises of 0% and 2.32%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Is Henry Schein Gaining or Losing Market Support? - Henry Schein ( NASDAQ:HSIC )
Henry Schein's HSIC short percent of float has fallen 16.17% since its last report. The company recently reported that it has 5.77 million shares sold short, which is 5.34% of all regular shares that are available for trading.
Earnings Preview: Dentsply International ( XRAY ) Q4 Earnings Expected to Decline
Dentsply (XRAY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Unveiling Henry Schein ( HSIC ) Q4 Outlook: Wall Street Estimates for Key Metrics
Besides Wall Street's top -and-bottom-line estimates for Henry Schein (HSIC), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2024.
HSIC Gears Up for Q4 Earnings: Here's What You Need to Know
Henry Schein is expected to report impressive sales in both its businesses in the fourth quarter of 2024, along with a positive pace of recovery from the cyber incident.
This Analog Devices Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Analog Devices ( NASDAQ:ADI ) , Align Tech ( NASDAQ:ALGN )
Top Wall Street analysts initiated coverage on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Wells Fargo analyst Vik Chopra initiated coverage on Henry Schein, Inc.
Zacks Industry Outlook Enovis, Omnicell and Phreesia
Enovis, Omnicell and Phreesia have been highlighted in this Industry Outlook article.
